Johnson & Johnson appeared to turn the tide in the talcum powder litigation this year—with a big boost from the U.S. Supreme Court.

Johnson & Johnson was hit with a trio of double-digit verdicts out of Missouri in 2016, and now faces lawsuits by more than 5,000 women alleging its iconic baby powder and Shower to Shower products caused them to get ovarian cancer. But a new legal team out of Proskauer Rose’s Los Angeles office scored the first defense win earlier this year—then got a record $417 million verdict in California thrown out. And Johnson & Johnson got a big boost in June with the U.S. Supreme Court’s ruling in Bristol-Myers Squibb v. Superior Court of California, which prompted a mistrial, reversal of a $72 million verdict and a halt to the Missouri trials.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]